As the omicron variant sends U.S. Covid case numbers soaring to new records and drugstores and walk-in clinics clamor for test kits, suppliers have been struggling with their own mounting problems.
BioNTech SE, Moderna Inc. and Johnson & Johnson are working to adapt their COVID-19 vaccines to address the omicron variant, with the German partner of Pfizer Inc. saying it could have a new version ready within 100 days if necessary.
Controlant, a provider of innovative technology for monitoring the distribution of temperature-sensitive vaccines and other items in the cold chain, takes on COVID-19.
Management Sciences for Health, with funding from USAID and in cooperation with multiple private and public entities in Ukraine, launches a successful pilot to improve that country’s healthcare delivery supply chain.
More than 10 months after U.S. regulators first authorized its potent shot, Moderna is finding that inventing a COVID-19 vaccine was actually a relatively straightforward task compared with what would come next: ramping up vial-filling operations on multiple continents and distributing the vaccine to countries around the world in the middle of a devastating pandemic.
The Council of Supply Chain Management Professionals (CSCMP) and SupplyChainBrain presented their annual Supply Chain Innovation Award on Wednesday to global health care nonprofit Management Sciences for Health’s (MSH) for streamlining distribution of HIV and TB medicines to vulnerable communities in Ukraine.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.